Varex Imaging Corporation (VREX): Price and Financial Metrics
Varex Imaging Corporation (VREX)
Today's Latest Price: $16.50 USD
Updated Dec 1 4:00pm
Add VREX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
VREX Stock Summary
- Varex Imaging Corp's stock had its IPO on January 30, 2017, making it an older stock than merely 13.45% of US equities in our set.
- Price to trailing twelve month operating cash flow for VREX is currently 49, higher than 91.65% of US stocks with positive operating cash flow.
- Over the past twelve months, VREX has reported earnings growth of -175.33%, putting it ahead of just 11.3% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Varex Imaging Corp are VSTM, SCOR, PAR, MDRX, and ITRI.
- VREX's SEC filings can be seen here. And to visit Varex Imaging Corp's official web site, go to www.vareximaging.com.
VREX Stock Price Chart Interactive Chart >
VREX Price/Volume Stats
| Current price | $16.50 | 52-week high | $32.21 |
| Prev. close | $16.68 | 52-week low | $10.36 |
| Day low | $16.46 | Volume | 502,000 |
| Day high | $17.09 | Avg. volume | 434,117 |
| 50-day MA | $13.89 | Dividend yield | N/A |
| 200-day MA | $17.08 | Market Cap | 645.15M |
Varex Imaging Corporation (VREX) Company Bio
Varex Imaging Corporation. spun off from Varian Medical Systems, is focused on being a high-volume manufacturer of X-ray tubes, flat panel detectors and high-voltage connectors as well as a supplier of imaging software and specialized accelerators for high-energy x-ray imaging.
VREX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $16.50 | $0.78 | -95% |
We started the process of determining a valid price forecast for Varex Imaging Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Varex Imaging Corp ranked in the 7th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 95%. As for the metrics that stood out in our discounted cash flow analysis of Varex Imaging Corp, consider:
- The company's compound free cash flow growth rate over the past 4.01 years comes in at -0.19%; that's greater than only 8.52% of US stocks we're applying DCF forecasting to.
- The company has produced more trailing twelve month cash flow than merely 19.42% of its sector Healthcare.
- Varex Imaging Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.18. This coverage rate is greater than that of merely 24.88% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -95% |
| 1% | -95% |
| 2% | -95% |
| 3% | -95% |
| 4% | -95% |
| 5% | -95% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as VREX, try LUMO, NVST, OSMT, COO, and EW.
Loading social stream, please wait...